“…With a reported sensitivity as high as 87%, sestamibi has become a standard technique in preoperative parathyroid imaging. Its sensitivity decreases in patients with multiglandular parathyroid disease, thyroid nodules, and medical conditions such as sarcoidosis and lymphoma; ultrasonography is a useful adjunct for parathyroid localization in these patients [23][24][25]. For surgeons performing MIP, sestamibi is frequently the only preoperative imaging modality obtained.…”